Advanced Microfluidics for Single Cell‐Based Cancer Research
Advanced Science · 2025
DOI: 10.1002/advs.202500975 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Science, 2025. Verfasst von Adriana Carneiro und 10 weiteren Autor:innen. Beteiligte Einrichtung: INL - International Iberian Nanotechnology Laboratory, Avenida Mestre José Veiga, s/n, Braga, 4715-330, Portugal. Hauptthemen laut MEDLINE: Neoplasms, Microfluidics, Single-Cell Analysis. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 148 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: UK Research and Innovation, Fundação para a Ciência e a Tecnologia, H2020 Future and Emerging Technologies.
Abstract (Originalsprache)
Cancer remains one of the leading causes of mortality worldwide, accounting for ≈10 million deaths annually. Critically, it is metastasis and not the primary tumour that causes most of these deaths. Understanding the mechanisms behind cancer dissemination and therapy resistance is thus a pressing challenge. Traditional bulk tissue analyses have failed to capture the full spectrum of intra‐tumour heterogeneity and the dynamic interactions within the tumour microenvironment. Studying cancer at the single‐cell level allows unravelling the roles of rare subpopulations, cell–cell interactions, and spatial dynamics that govern tumour evolution, metastasis, and immune evasion. This review explores how recent advances in microfluidic technologies are transforming ability to model and study cancer at the single‐cell level. Cutting‐edge platforms are highlighted, including droplet microfluidics, single cell‐derived spheroids, and tumour‐chips, that enable physiologically relevant 3D cancer models. By integrating immune components, biosensing, and patient‐derived materials, these platforms hold promise for advancing drug screening, immunotherapy assessment, and personalised medicine. It is concluded by identifying key challenges and priorities for future work, which should focus on increasing model complexity, reproducibility, and integration of spatiotemporal multiomics to better dissect tumour heterogeneity and accelerate clinical translation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- INL - International Iberian Nanotechnology Laboratory, Avenida Mestre José Veiga, s/n, Braga, 4715-330, Portugal.
- Experimental Pathology and Therapeutics Group, Research Centre of IPO Porto / RISE @ CI-IPOP (Health Research Network), Portuguese Institute of Oncology - Porto, Porto Comprehensive Cancer Centre (Porto.CCC), Porto, 420…
- Instituto de Ciências Biomédicas Abel Salazar (ICBAS) da Universidade do Porto, R. Jorge de Viterbo Ferreira 228, Porto, 4050-313, Portugal.
ORCID-Profile: Adriana Carneiro, Marta Aranda Palomer, Margarida Esteves, Carolina Rodrigues, José Maria Fernandes, Francisca Oliveira, Alexandra Teixeira, Carlos Honrado, Lorena Dieguez, Sara Abalde-Cela, Miguel Xavier
Förderung
- UK Research and Innovation
- Fundação para a Ciência e a Tecnologia
- H2020 Future and Emerging Technologies
- HORIZON EUROPE Marie Sklodowska-Curie Actions
- HORIZON EUROPE European Innovation Council
Zitieren
APA
Carneiro, A., Aranda Palomer, M., Esteves, M., Rodrigues, C., Fernandes, J. M., Oliveira, F., Teixeira, A., Honrado, C., Dieguez, L., Abalde-Cela, S., & Xavier, M. (2025). Advanced Microfluidics for Single Cell‐Based Cancer Research. Advanced Science. https://doi.org/10.1002/advs.202500975
Vancouver
Carneiro A, Aranda Palomer M, Esteves M, Rodrigues C, Fernandes JM, Oliveira F, et al. Advanced Microfluidics for Single Cell‐Based Cancer Research. Advanced Science. 2025. doi:10.1002/advs.202500975
BibTeX
@article{Carneiro2025,
author = {Carneiro, Adriana and Aranda Palomer, Marta and Esteves, Margarida and Rodrigues, Carolina and Fernandes, José Maria and Oliveira, Francisca and Teixeira, Alexandra and Honrado, Carlos and Dieguez, Lorena and Abalde-Cela, Sara and Xavier, Miguel},
title = {Advanced Microfluidics for Single Cell‐Based Cancer Research},
journal = {Advanced Science},
year = {2025},
doi = {10.1002/advs.202500975}
}
EUVIMED